SCHEMBL20857078

SCHEMBL20857078

C=C(C)CNCCn1cnc(C(=O)OCC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.40
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 1/20 0.36
CYP1A2 P05177 1/20 0.35
GAA P10253 3/20 0.34
SMYD3 Q9H7B4 1/20 0.34
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
GLA P06280 2/20 0.32
TBXAS1 P24557 2/20 0.32
CPB2 Q96IY4 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20857079 0.83 NOTUM (0.40) NOTUMKDM4EALDH1A1HPGDCYP1A2
SCHEMBL22859643 0.82 NOTUM (0.45) NOTUMKDM4EALDH1A1HPGDCYP1A2
SCHEMBL20868509 0.82 NOTUM (0.45) NOTUMKDM4EALDH1A1HPGDCYP1A2
SCHEMBL22480272 0.81 NOTUM (0.43) NOTUMKDM4EALDH1A1HPGDCYP1A2
SCHEMBL28934829 0.79 NOTUM (0.49) NOTUMKDM4EALDH1A1HPGDCYP1A2
SCHEMBL23059425 0.79 NOTUM (0.43) NOTUMKDM4EALDH1A1HPGDCYP1A2
SCHEMBL25884465 0.78 NOTUM (0.42) NOTUMKDM4EALDH1A1HPGDCYP1A2
SCHEMBL24036185 0.77 NOTUM (0.48) NOTUMKDM4EALDH1A1HPGDCYP1A2
SCHEMBL28896965 0.77 NOTUM (0.41) NOTUMKDM4EALDH1A1HPGDCYP1A2
SCHEMBL20857112 0.76 NOTUM (0.47) NOTUMKDM4EALDH1A1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3946463-A1 COMPOSITIONS, DEVICES AND METHODS FOR FACTOR VII THERAPY Sigilon Therapeutics, Inc. (US) 2022-02-09 EP disclosed
EP-3773517-A1 IMPLANTABLE PARTICLES AND RELATED METHODS Sigilon Therapeutics, Inc. (US) 2021-02-17 EP disclosed
WO-2020198695-A1 COMPOSITIONS, DEVICES AND METHODS FOR FACTOR VII THERAPY SIGILON THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed
EP-3687580-A1 METHODS, COMPOSITIONS, AND IMPLANTABLE ELEMENTS COMPRISING ACTIVE CELLS Sigilon Therapeutics, Inc. (US) 2020-08-05 EP disclosed
WO-2019195055-A1 IMPLANTABLE PARTICLES AND RELATED METHODS SIGILON THERAPEUTICS, INC. (US) 2019-10-10 WO disclosed
WO-2019195056-A1 METHODS, COMPOSITIONS, AND IMPLANTABLE ELEMENTS COMPRISING STEM CELLS SIGILON THERAPEUTICS, INC. (US) 2019-10-10 WO disclosed
WO-2019067766-A1 METHODS, COMPOSITIONS, AND IMPLANTABLE ELEMENTS COMPRISING ACTIVE CELLS SIGILON THERAPEUTICS, INC. (US) 2019-04-04 WO disclosed